Literature DB >> 3319645

Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold stimulation in essential hypertension.

T Takabatake1, Y Yamamoto, S Nakamura, N Hashimoto, S Satoh, Y Yamada, H Ohta, N Hattori.   

Abstract

The immediate haemodynamic effects of the calcium antagonist nilvadipine have been studied in ten patients with established mild essential hypertension. Nilvadipine 4 mg p.o. reduced both the systolic and diastolic blood pressures within 60 min, associated with a fall in total peripheral resistance and an increase in heart rate and cardiac index. The peak of blood pressure and total peripheral resistance reached during a cold pressor test were reduced by nilvadipine, but it did not affect the haemodynamic responsiveness to cold stimulation. Plasma renin activity was unaltered and the plasma noradrenaline concentration was increased only slightly. Thus, nilvadipine lowered blood pressure at rest and during cold stimulation as a result of arteriolar dilatation. The hypotensive effect at rest was associated with a reflex increase in heart rate and cardiac index.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319645     DOI: 10.1007/BF00637551

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Comparison of acute effects of nifedipine in normotensive and hypertensive man.

Authors:  O Lederballe Pedersen; N J Christensen; K D Rämsch
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

2.  The effect of nifedipine on arterial pressure and reflex cardiac control.

Authors:  R A McLeay; T J Stallard; R D Watson; W A Littler
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

3.  Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension.

Authors:  H O Ventura; F H Messerli; W Oigman; F G Dunn; E Reisin; E D Frohlich
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

4.  The release of noradrenaline from sympathetic fibres in relation to calcium concentration.

Authors:  J H Burn; W R Gibbons
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

5.  Determination of nilvadipine in human plasma by capillary column gas chromatography-negative-ion chemical-ionization mass spectrometry.

Authors:  Y Tokuma; T Fujiwara; H Noguchi
Journal:  J Chromatogr       Date:  1985-11-29

6.  Blood pressure variability and hemodynamic response to stress in patients with paroxysmal elevation of blood pressure.

Authors:  T Takabatake; Y Yamamoto; H Ohta; S Nakamura; H Hara; Y Ishida; N Hashimoto; N Hattori
Journal:  Clin Exp Hypertens A       Date:  1985

7.  Hypotensive effects of diltiazem to normals and essential hypertensives.

Authors:  K Aoki; K Sato; S Kondo; M Yamamoto
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.

Authors:  M Ohtsuka; T Ono; J Hiroi; K Esumi; H Kikuchi; S Kumada
Journal:  J Cardiovasc Pharmacol       Date:  1983 Nov-Dec       Impact factor: 3.105

9.  Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity.

Authors:  D C Warltier; M G Zyvoloski; G J Gross; H L Brooks
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

10.  Antihypertensive effect of nicardipine hydrochloride in essential hypertension.

Authors:  T Takabatake; H Ohta; Y Yamamoto; M Maekawa; S Arai; N Hattori; G Nomura
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-08
View more
  5 in total

1.  Effect of nicardipine on haemodynamic response to stress in hypertension.

Authors:  T Takabatake; Y Yamamoto; S Nakamura; N Hashimoto; S Satoh; Y Yamada; K Kobayashi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.

Authors:  J Minami; Y Kawano; Y Makino; H Matsuoka; S Takishita
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

3.  Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.

Authors:  Y Takata; T Yoshizumi; Y Ito; M Kikuchi; M Ueno; A Tsukashima; K Kobayashi; M Fujishima
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.

Authors:  R N Brogden; D McTavish
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

5.  Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study.

Authors:  M Hori; H Sato; M Karita; K Kodama; N Hoki; T Hayashi; M Naka; S Nanto; Y Yamada; T Kamada
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.